83 related articles for article (PubMed ID: 23695404)
1. Peyronie's disease: a "triple oxygenant therapy".
Ciociola F; Colpi GM
Arch Ital Urol Androl; 2013 Apr; 85(1):36-40. PubMed ID: 23695404
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of verapamil efficacy in Peyronie's disease comparing with pentoxifylline.
Alizadeh M; Karimi F; Fallah MR
Glob J Health Sci; 2014 Sep; 6(7 Spec No):23-30. PubMed ID: 25363175
[TBL] [Abstract][Full Text] [Related]
3. The role of PDE5 inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomes.
Chung E; Deyoung L; Brock GB
J Sex Med; 2011 May; 8(5):1472-7. PubMed ID: 21324095
[TBL] [Abstract][Full Text] [Related]
4. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures.
Valente EG; Vernet D; Ferrini MG; Qian A; Rajfer J; Gonzalez-Cadavid NF
Nitric Oxide; 2003 Dec; 9(4):229-44. PubMed ID: 14996430
[TBL] [Abstract][Full Text] [Related]
5. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial.
Palmieri A; Imbimbo C; Creta M; Verze P; Fusco F; Mirone V
Int J Androl; 2012 Apr; 35(2):190-5. PubMed ID: 22085227
[TBL] [Abstract][Full Text] [Related]
6. Ten-year experience with multimodal treatment for acute phase Peyronie's disease: A real life clinical report.
Gallo L; Sarnacchiaro P
Actas Urol Esp (Engl Ed); 2019 May; 43(4):182-189. PubMed ID: 30704797
[TBL] [Abstract][Full Text] [Related]
7. A combination of phosphodiesterase type 5 inhibitor and tamoxifen for acute Peyronie's disease: the first clinical signals.
Cellek S; Megson M; Ilg MM; Ralph DJ
J Sex Med; 2023 Jul; 20(8):1057-1059. PubMed ID: 37524687
[No Abstract] [Full Text] [Related]
8. Management of Peyronie's disease--a review.
Tunuguntla HS
World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
[TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
[TBL] [Abstract][Full Text] [Related]
10. The treatment of loss of penile rigidity associated with Peyronie's disease.
Krane RJ
Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
[TBL] [Abstract][Full Text] [Related]
11. Endothelial antioxidant compound prolonged the endothelial antiapoptotic effects registered after tadalafil treatment in patients with arterial erectile dysfunction.
La Vignera S; Condorelli R; Vicari E; D'Agata R; Calogero AE
J Androl; 2012; 33(2):170-5. PubMed ID: 21546612
[TBL] [Abstract][Full Text] [Related]
12. Pentoxifylline treatment and penile calcifications in men with Peyronie's disease.
Smith JF; Shindel AW; Huang YC; Clavijo RI; Flechner L; Breyer BN; Eisenberg ML; Lue TF
Asian J Androl; 2011 Mar; 13(2):322-5. PubMed ID: 21102473
[TBL] [Abstract][Full Text] [Related]
13. Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study.
Fitch WP; Easterling WJ; Talbert RL; Bordovsky MJ; Mosier M
J Sex Med; 2007 Mar; 4(2):477-84. PubMed ID: 17367443
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Peyronie's disease with oral pentoxifylline.
Brant WO; Dean RC; Lue TF
Nat Clin Pract Urol; 2006 Feb; 3(2):111-5; quiz 116. PubMed ID: 16470210
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of erectile dysfunction in patients with plastic induration of the penis].
Sokol'shchik MM; Gagarina SV; Petrovich RIu; Sadakova IV
Urologiia; 2008; (1):41-4. PubMed ID: 18649679
[TBL] [Abstract][Full Text] [Related]
16. Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease.
Abern MR; Larsen S; Levine LA
J Sex Med; 2012 Jan; 9(1):288-95. PubMed ID: 22024053
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological therapy in patients diagnosed with Peyronie's disease.
Halal AA; Geavlete P; Ceban E
J Med Life; 2012 Jun; 5(2):192-5. PubMed ID: 22802890
[TBL] [Abstract][Full Text] [Related]
18. A new, innovative, lengthening surgical procedure for Peyronie's disease by penile prosthesis implantation with double dorsal-ventral patch graft: the "sliding technique".
Rolle L; Ceruti C; Timpano M; Sedigh O; Destefanis P; Galletto E; Falcone M; Fontana D
J Sex Med; 2012 Sep; 9(9):2389-95. PubMed ID: 22429331
[TBL] [Abstract][Full Text] [Related]
19. SOP conservative (medical and mechanical) treatment of erectile dysfunction.
Porst H; Burnett A; Brock G; Ghanem H; Giuliano F; Glina S; Hellstrom W; Martin-Morales A; Salonia A; Sharlip I;
J Sex Med; 2013 Jan; 10(1):130-71. PubMed ID: 23343170
[TBL] [Abstract][Full Text] [Related]
20. Incision and grafting for severe Peyronie's disease (CME).
Richardson B; Pinsky MR; Hellstrom WJ
J Sex Med; 2009 Aug; 6(8):2084-7; quiz 2088. PubMed ID: 19682225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
